1. Home
  2. BANR vs AMPH Comparison

BANR vs AMPH Comparison

Compare BANR & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banner Corporation

BANR

Banner Corporation

HOLD

Current Price

$63.34

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$27.02

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BANR
AMPH
Founded
1890
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.2B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
BANR
AMPH
Price
$63.34
$27.02
Analyst Decision
Buy
Buy
Analyst Count
6
6
Target Price
$71.20
$31.00
AVG Volume (30 Days)
193.4K
380.6K
Earning Date
01-21-2026
11-06-2025
Dividend Yield
3.12%
N/A
EPS Growth
14.84
N/A
EPS
5.49
2.27
Revenue
$640,027,000.00
$723,305,000.00
Revenue This Year
$0.96
$1.35
Revenue Next Year
$7.48
$5.10
P/E Ratio
$11.67
$11.81
Revenue Growth
7.86
N/A
52 Week Low
$54.01
$20.39
52 Week High
$72.58
$39.01

Technical Indicators

Market Signals
Indicator
BANR
AMPH
Relative Strength Index (RSI) 42.37 55.28
Support Level $66.40 $26.26
Resistance Level $67.95 $27.23
Average True Range (ATR) 1.22 0.76
MACD -0.42 0.06
Stochastic Oscillator 3.01 85.96

Price Performance

Historical Comparison
BANR
AMPH

About BANR Banner Corporation

Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: